Sign in

CONAGRA BRANDS INC. (CAG) Q2 2025 Earnings Summary

Executive Summary

  • Q2 FY25 was a mixed quarter: organic net sales returned to growth (+0.3%) with volumes +0.4%, but adjusted operating margin compressed to 15.3% (-57 bps YoY) as higher input inflation and FX offset productivity; adjusted EPS was $0.70 (-1.4% YoY) while reported EPS was $0.59 (-1.7% YoY) .
  • Management cut FY25 outlook: adj. operating margin to ~14.8% (from 15.6–15.8%), adj. EPS to $2.45–$2.50 (from $2.60–$2.65), and raised FCF conversion to >100%; drivers are higher-than-expected inflation (esp. protein; cocoa/sugar also) and FX headwinds .
  • Category execution improved: Grocery & Snacks net sales +2.0% with adj. OI +4.8%, Refrigerated & Frozen volumes +1.9% but price/mix -1.9% (adj. OI -10.8%); International pressured by M&A/FX; Foodservice down modestly with traffic softness .
  • Call color: no “Thanksgiving timing” effect; trade investment underspend in Q2 redeployed to Q3; Q3 operating margin expected to trough with Q4 recovery; pricing selective (offsetting cocoa/sugar) while preserving volume momentum amid deferred protein cost relief .
  • Street estimates: S&P Global consensus was unavailable at time of analysis due to access limits; versus prior company guidance, the quarter’s narrative and guide cut likely reset expectations lower (see Guidance Changes) .

What Went Well and What Went Wrong

  • What Went Well

    • Volume-led return to growth: organic volume +0.4% and organic sales +0.3%; total gross margin held flat YoY at 26.5% despite inflation (adj. GM 26.4%) .
    • Grocery & Snacks outperformed: net sales +2.0% with price/mix +0.9% and volume +0.3%; adj. OI +4.8% to $296M; share gains in popcorn, dinners/entrees, chili, seeds .
    • Strong free cash flow discipline: H1 FY25 FCF $538.8M; net debt reduced to $8.43B; TTM leverage 3.54x .
    • Management quote: “Our business returned to growth in the second quarter… our investments paid off, driving strong market share performance” .
  • What Went Wrong

    • Margin pressure from cost inflation/FX: adj. operating margin fell to 15.3% (-57 bps YoY); adj. gross profit -2.3% YoY (to $842M) .
    • Refrigerated & Frozen profit decline: flat sales on -1.9% price/mix and +1.9% volume; adj. OI -10.8% as COGS inflation and operating leverage weighed .
    • International headwinds: net sales -12.9% (M&A -8.4%, FX -3.8%); adj. OI -2.9% .
    • Analyst concerns: increased H2 inflation (~4%) and deferred protein cost relief forced guide down; limited new pricing to protect volume momentum .

Financial Results

MetricQ2 FY24Q1 FY25Q2 FY25
Net Sales ($B)$3.208 $2.795 $3.195
Reported Diluted EPS ($)$0.60 $0.97 $0.59
Adjusted EPS ($)$0.71 $0.53 $0.70
Gross Margin (%) – Reported26.4% 26.5% 26.5%
Gross Margin (%) – Adjusted26.9% 26.0% 26.4%
Operating Margin (%) – Reported14.0% 14.4% 12.6%
Operating Margin (%) – Adjusted15.9% 14.2% 15.3%
Adjusted EBITDA ($M)$660.7 $527.7 $638.9

Segment Net Sales ($B)

SegmentQ2 FY24Q2 FY25
Grocery & Snacks$1.295 $1.321
Refrigerated & Frozen$1.339 $1.339
International$0.280 $0.243
Foodservice$0.295 $0.292
Total$3.208 $3.195

Adjusted Operating Profit ($M)

SegmentQ2 FY24Q2 FY25
Grocery & Snacks$281.9 $295.7
Refrigerated & Frozen$222.2 $198.1
International$40.6 $39.4
Foodservice$35.4 $35.8
Corporate$(69.8) $(78.9)
Total$510.3 $490.1

Q2 FY25 KPI Decomposition (% YoY, Organic)

SegmentPrice/MixVolume
Total Conagra(0.1)% +0.4%
Grocery & Snacks+0.9% +0.3%
Refrigerated & Frozen(1.9)% +1.9%
International+1.7% (2.4)%
Foodservice+2.9% (3.9)%

Cash Flow and Leverage (YTD through Q2)

MetricQ2 FY24 YTDQ2 FY25 YTD
Cash from Operations ($M)$854.6 $754.2
Capex ($M)$214.0 $215.4
Free Cash Flow ($M)$640.6 $538.8
Net Debt ($B)$9.01 $8.43
Net Leverage (TTM)3.55x 3.54x

Guidance Changes

MetricPeriodPrevious Guidance (Q1 FY25)Current Guidance (Q2 FY25)Change
Organic Net Sales vs FY24FY25(1.5)% to Flat (1.5)% to Flat, ~midpoint Maintained
Adjusted Operating MarginFY2515.6%–15.8% ~14.8% Lowered
Adjusted EPSFY25$2.60–$2.65 $2.45–$2.50 Lowered
Free Cash Flow ConversionFY25~90% >100% Raised
Adjusted Effective Tax RateFY25~23.5% ~23.0% Lowered
Net LeverageFY25~3.2x ~3.4x Higher (on lower profit)
Inflation (net)FY25~3.2% ~4% Higher
Capital ExpendituresFY25~$450M ~$450M (unchanged) Maintained
Interest ExpenseFY25~$415M Unchanged Maintained
Ardent Mills ContributionFY25~$150M Unchanged Maintained
Pension IncomeFY25~$12M Unchanged Maintained

Why the change: management cited higher-than-expected inflation (notably protein; also cocoa/sugar) and unfavorable FX in H2; selective pricing to offset cocoa/sugar while preserving top-line momentum; protein cost relief deferred .

Earnings Call Themes & Trends

TopicPrevious Mentions (Q4 FY24, Q1 FY25)Current Period (Q2 FY25)Trend
Brand investments/tradeEmphasis on brand-building; A&P up; strategic investments pressuring price/mix; reaffirmed FY25 outlook Q2 trade underspend redeployed to Q3; investments working, driving share; no cut to support Continued/increasing support
Inflation & pricingFY25 net inflation ~3.0–3.2% expected Full-year ~4%; selective pricing for cocoa/sugar; defer broad pricing to protect volumes Inflation worse; cautious pricing
Protein costsNot highlighted as main driver priorProtein is the larger cost driver; relief deferred to later New headwind
FXNot a major focusFX a headwind to H2 and International segment Worsening
Supply chain/inventoryProductivity helped margins; Hebrew National disruption in Q1 No Thanksgiving timing impact; shipments and consumption aligned; small hurricane benefit in G&S Stable
Frozen category dynamicsStrong share in frozen; innovation-led Frozen volumes +3.2%; share gains; competition adding capacity but CAG confident in leadership Positive
GLP-1/healthN/A“On Track” GLP-1-friendly wayfinder on Healthy Choice; positioning for on/off-ramp consumers Emerging opportunity
Leverage/FCFFY25 net leverage ~3.2x target; strong FCF in FY24 FY25 net leverage ~3.4x on lower profit; still targeting ~3.0x by FY26; FCF conversion >100% Slightly negative near term, path intact

Management Commentary

  • “Our business returned to growth in the second quarter despite a continued challenging consumer environment as our investments paid off, driving strong market share performance.” — Sean Connolly, CEO .
  • “There really was not a Thanksgiving timing effect for our company... our inventory levels with customers were essentially even with the year ago.” — Sean Connolly .
  • “The EPS call down today equates basically identically to the inflation in the back half versus what we had previously expected, that's the majority of it, plus FX.” — Sean Connolly .
  • “We do believe operating margin will be the lowest of all the quarters for the year [in Q3]... inflation will be higher in Q3 than Q4.” — Dave Marberger, CFO .

Q&A Highlights

  • Trade spend and timing: Q2 trade came in below plan and was redeployed to Q3; management reiterated that investments have been in place five quarters and are working to drive volumes/share .
  • Inflation and pricing posture: Incremental H2 inflation (protein primary; cocoa/sugar also) plus FX drove the guide cut; limited new pricing to protect momentum, with targeted pricing for cocoa/sugar .
  • Margin cadence: Q3 operating margin expected to be the lowest of the year with recovery in Q4; additional slotting/innovation and higher inflation load in Q3 cited .
  • Consumption vs shipments: No Thanksgiving timing benefit; shipments +1% vs consumption +0.6%; channel inventory even YoY .
  • Category/strategy: Confidence in frozen leadership amid competitor capacity adds; GLP-1-friendly “On Track” messaging on Healthy Choice to capture health trends .

Estimates Context

  • S&P Global consensus EPS/revenue estimates were unavailable at the time of analysis due to access limitations; therefore, we cannot present vs-consensus comparisons for Q2 FY25 or FY25. We note company guidance was reduced (adj. EPS $2.45–$2.50; adj. operating margin ~14.8%), which likely implies lower Street trajectory near term absent a cost/inflation reversal .

Key Takeaways for Investors

  • Volume momentum returned with organic growth and broad share gains, especially in frozen and snacks; management is prioritizing sustained investment to protect this momentum .
  • Guidance reset reflects higher H2 inflation (~4%) and FX; watch protein cost curves and FX as key sensitivities into Q3/Q4 .
  • Margin trough anticipated in Q3 with recovery in Q4 as investment timing and inflation cadence normalize; any upside requires faster cost relief and/or improved operating leverage .
  • Refrigerated & Frozen profitability is the swing factor: volumes improved but price/mix and cost inflation pressured margins; execution on productivity and mix will be crucial .
  • Strong cash discipline underpins >100% FY25 FCF conversion and continued deleveraging; leverage expected ~3.4x in FY25 with a path to ~3.0x by FY26 per management .
  • Selective pricing (cocoa/sugar) suggests limited margin recapture near term; the strategy aims to defend volumes/share vs. value-seeking consumers and a rational promotional backdrop .
  • Tactical watch items for trading: Q3 margin trough vs expectations, protein cost trajectory, frozen category consumption trends, and the magnitude of any Q4 recovery in operating margin .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%